Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Which credit card has the best travel rewards program? This guide helps you compare top options to maximize your travel rewards.
28,014 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Bitcoin sits around $66,800 as the BITO ETF regains attention amid competition from cheaper spot BTC products. Invest...
Aluminium Bahrain B.S.C. (Alba) has begun a phased shutdown of three production lines, slashing about 19% of its capa...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
Energy Select Sector SPDR Fund (XLE) has staged a rebound as crude hits higher levels. Two key signals could set the ...
A coalition of over 200 crypto firms is pressing Congress for a floor vote on the CLARITY Act, warning that time is r...
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...
VOO crossed the $1 trillion mark, the first ETF ever to do so. Yet nearly 40% of the fund sits in mega-cap tech names...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
Fort Baker’s decision to liquidate its TGNA position signals shifting beliefs about the media stock. This guide break...
Bitcoin slid to a two-week low near $78,000 after a brief run to the mid-80s, throwing cold water on a quick bear-mar...